Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma
Anna E. Coghill(Moffitt Cancer Center), Jian‐Min Yuan(University of Pittsburgh), Woon‐Puay Koh(St. Elizabeth's Hospital), Andrew T. McGuire(University of Washington), Anton M. Sholukh(Fred Hutch Cancer Center), Irika R. Sinha(Johns Hopkins University), Leah J. Homad(Fred Hutch Cancer Center), Sweta Sinha(Unknown)
Cited by 11
Related Papers
Epidemiology of nasopharyngeal carcinoma
|Seminars in Cancer Biology|2002|941
Dietary Factors and Risk of Breast Cancer: Combined Analysis of 12 Case--Control Studies
|JNCI Journal of the National Cancer Institute|1990|756
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
|The Lancet|1992|731
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.
|PubMed|1994|677
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium
|Journal of Clinical Oncology|2016|517